Subject
Neurology,Molecular Biology,Aging,Biochemistry,Biotechnology
Reference76 articles.
1. Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis;Ackley;BMJ (Clin. Res. Ed. ),2021
2. A Phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease;Aisen;Neurology,2006
3. Tramiprosate in mild-to-moderate Alzheimer's disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study);Aisen,2011
4. First administration of the Fc-attenuated anti-beta amyloid antibody GSK933776 to patients with mild Alzheimer's disease: a randomized, placebo-controlled study;Andreasen;PloS One,2015
5. Vanutide cridificar and the QS-21 adjuvant in Japanese subjects with mild to moderate Alzheimer's disease: results from two phase 2 studies;Arai;Curr. Alzheimer Res.,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献